Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798316
Max Phase: Preclinical
Molecular Formula: C22H22F3NO5S
Molecular Weight: 469.48
Molecule Type: Unknown
Associated Items:
ID: ALA4798316
Max Phase: Preclinical
Molecular Formula: C22H22F3NO5S
Molecular Weight: 469.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cccc2c1S(=O)(=O)N(C(=O)c1ccc(C(F)(F)F)cc1)C2CC(=O)OC(C)(C)C
Standard InChI: InChI=1S/C22H22F3NO5S/c1-13-6-5-7-16-17(12-18(27)31-21(2,3)4)26(32(29,30)19(13)16)20(28)14-8-10-15(11-9-14)22(23,24)25/h5-11,17H,12H2,1-4H3
Standard InChI Key: JAGVFUBZGPNSRF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 469.48 | Molecular Weight (Monoisotopic): 469.1171 | AlogP: 4.63 | #Rotatable Bonds: 3 |
Polar Surface Area: 80.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.98 | CX Basic pKa: | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.61 | Np Likeness Score: -0.92 |
1. Ma Y,Li X,Pei Y,Ye J,Wei X,Yang J,Si G,Tian J,Dong Y,Liu G. (2020) Identification of benzofused five-membered sultams, potent dual NOD1/NOD2 antagonists in vitro and in vivo., 204 [PMID:32731185] [10.1016/j.ejmech.2020.112575] |
Source(1):